Imagin Medical (IMEXF) Stock Price, News & Analysis

Company Overview

Imagin Medical Technologies Inc. is a development‐stage medical device company focused on enhancing the detection and management of bladder cancer through advanced optical imaging. The company’s proprietary technology leverages near‐infrared fluorescence to improve visualization of malignant and pre‐malignant lesions that can be difficult to detect using conventional white‐light cystoscopy.

The flagship Imagin™ System integrates a compact imaging console, single‐use catheter sheaths and a targeted fluorophore to selectively highlight cancerous tissue within the bladder. During a standard cystoscopic procedure, the fluorophore accumulates in abnormal cells, emitting a near‐infrared signal that the console’s high‐sensitivity camera captures, allowing physicians to more accurately locate and resect tumors.

The Imagin™ System is advancing through regulatory review and early clinical evaluation in North America. Initial studies aim to demonstrate that the technology can reduce missed lesions, lower recurrence rates and potentially decrease the need for repeat surgeries. Imagin Medical is collaborating with leading urology centers to generate data on safety, efficacy and procedural integration.

Headquartered in Toronto, Canada, Imagin Medical builds on research partnerships with academic institutions in the fields of biomedical engineering and oncology. The company’s leadership team brings together professionals with experience in medical device development, clinical research and commercialization, positioning Imagin Medical to address unmet needs in urological cancer care.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: 10,434 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Medical Devices
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:IMEXF
• CIK: N/A
• Web: imaginmedical.com
• Phone: (833) 246-2446
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A